A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2006
11/22/2006	EP1244651B1 Diamidine compounds as dna minor groove binders
11/22/2006	EP1220682B1 Stabilized liquid polypeptide-containing pharmaceutical compositions
11/22/2006	EP1214098B1 Capsid-modified recombinant adenovirus and methods of use
11/22/2006	EP1120114B1 Compositions and methods for treating conditions responsive to estrogen
11/22/2006	EP1080070B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	EP0970104B1 Steroid sulfamates, method for the production and use thereof
11/22/2006	EP0942925B1 Inhibitors of interleukin-1 beta converting enzyme
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006	EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006	CN1867573A Process for the preparation of trans- or cis-diammoniumdichlorodihydroxyplatinum(iv) salts and derivatives and their use for the preparation of pharmaceutical active agents
11/22/2006	CN1867572A Proteasome inhibitors and methods of using the same
11/22/2006	CN1867569A 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents
11/22/2006	CN1867567A 1-'(e)-2-(phenyl)ethenyl-4-(arylalkoxy)-oxazole or -thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer
11/22/2006	CN1867566A Aminopyrones and their use as ATM inhibitors
11/22/2006	CN1867564A Process for preparing amino crotonyl compounds
11/22/2006	CN1867563A Novel imidazole derivatives and their use as pharmaceutical agents
11/22/2006	CN1867561A Novel triarylimidazoles
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867557A Substitute thiophenes and uses therof
11/22/2006	CN1867543A Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
11/22/2006	CN1867362A Cancer gene therapeutic drug
11/22/2006	CN1867361A Cancer gene therapeutic drug
11/22/2006	CN1867347A A method of extracting glycyrrhizic flavone and preparation for anticarcinogen
11/22/2006	CN1867344A Pharmaceutical composition comprising oxoplatin, the salts and derivatives thereof
11/22/2006	CN1867334A Quinolinone derivatives as inhibitors of c-fms kinase
11/22/2006	CN1867331A Thalidomide analogs as TNF-alpha modulators
11/22/2006	CN1867324A Use of effectors of glutaminyl and glutamate cyclases
11/22/2006	CN1865450A Fatty acid extract of Antrodiacamphorata mycelium and its uses
11/22/2006	CN1865445A scFvC6.5-sTrail fusion gene and protein, and its preparation
11/22/2006	CN1865444A scFvC6.5-TNF-alpha fusion gene and protein, and its preparation
11/22/2006	CN1865285A Specific anti-human liver cancer phage single-chain antibody HscFv4-16 gene and its uses
11/22/2006	CN1865284A Receptor of the edb-fibronectin domains
11/22/2006	CN1865281A Specific antibody GB11 T cell epitope peptide for resisting oophoroma and its uses
11/22/2006	CN1865275A Artificial single-chain deoxynucleotide having therapeutic effect to human B cell tumour
11/22/2006	CN1865252A 4,5-di-substituted-phenyl-1,2,3-thiadia-zole derivative, and its preparation method and uses
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1864743A Methods for the treatment of insulin resistance and disease states characterized by insulin resistance
11/22/2006	CN1864737A Powder dedicated for treating leukemia and preparation method thereof
11/22/2006	CN1864734A A Chinese medicinal preparation for treating leukemia
11/22/2006	CN1864730A A cancer-treating medicine
11/22/2006	CN1864725A Method for extracting active ingredient of starofbethlehem and use thereof
11/22/2006	CN1864718A A polysaccharide composition for tumor aid treatment, its preparation and application
11/22/2006	CN1864714A Anticancer health food
11/22/2006	CN1864678A An anticancer pharmaceutical composition and preparation method thereof
11/22/2006	CN1285613C Antineoplastic rat light chain single domain antibody - Cefuroxime Sodium reinforced fusion protein VL-LDP-AE
11/22/2006	CN1285605C Antitumour indolo pyrrolo carbazole derivatives
11/22/2006	CN1285603C Synthesis of oxaliplatin
11/22/2006	CN1285602C 3,6-double(3-methyl pyridine-2yl)-S-tetrazine and transition metal complex, and its preparation and uses
11/22/2006	CN1285598C Method for preparing verticillium bacteria A and application
11/22/2006	CN1285588C Farnesyl protein transferase inhibitors
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285561C Alpha, beta-unsaturated ketone compound and its preparation process and GST-Pi inhibiting activity
11/22/2006	CN1285369C Chinese medicine for treating gynopathy
11/22/2006	CN1285365C Combination of Chinese traditional medicine in use for assistant treating cancer and preparation method
11/22/2006	CN1285338C Antilung gland cancer medicine, its preparation method and its application
11/21/2006	US7138547 Antitumoral compounds
11/21/2006	US7138543 Thiolalkyl benzoic acid derivatives
11/21/2006	US7138531 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
11/21/2006	US7138521 Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor
11/21/2006	US7138508 Inhibitor protein of the wnt signal pathway
11/21/2006	US7138507 primers for amplification of GST-pi mRNA in fixed and paraffin-embedded (FPE) tumor tissue; use in pharmacogenetics
11/21/2006	US7138501 Antibodies that immunospecifically bind BLyS
11/21/2006	US7138499 antibody that binds to a peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily
11/21/2006	US7138497 Genetic engineering; crosslinking polypeptide on carrier
11/21/2006	US7138490 of polyethylene glycols and polylactams with an impurities content of not more than 10% by weight; complex of polymer and an anthracycline anticancer drug, such as doxorubicin
11/21/2006	US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006	US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006	US7138428 Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cells and pharmaceutical compositions comprising the same
11/21/2006	US7138426 Estrogen receptor modulators
11/21/2006	US7138425 Phthalimide carboxylic acid derivatives
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138421 Anti-androgenic pyrrolidines with tumor-inhibiting action
11/21/2006	US7138420 Substituted benzimidazole compounds
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	US7138409 Heterocyclic compounds
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138402 Pyrrolopyrimidines and related analogs as HSP90-inhibitors
11/21/2006	US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006	US7138392 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
11/21/2006	US7138385 Thioarabinofuranosyl compounds and use thereof
11/21/2006	US7138383 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity
11/21/2006	US7138380 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
11/21/2006	US7138379 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons
11/21/2006	US7138377 Substituted sugar derivatives of indolopyrrolocarbazoles, useful in inhibiting the proliferatin of tumor cells
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006	US7138243 NTB-A, a surface molecule involved in natural killer cells activity
11/21/2006	US7138147 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies
11/21/2006	US7138146 Acrochordon alleviation
11/21/2006	US7138122 Therapeutic systems
11/21/2006	US7138103 Completitive binding

1 ... 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 ... 2211